Notice of Meeting, 46258 [2021-17714]
Download as PDF
<![CDATA[
46258
Federal Register / Vol. 86, No. 157 / Wednesday, August 18, 2021 / Notices
to plan, implement, and evaluate
vaccination programs for influenza and
COVID–19.
Amount of Award: $47,000,000 in
Federal Fiscal Year (FFY) 2021 funds,
and an estimated total of $100,000,000
over the five-year period of
performance, subject to availability of
funds.
Period of Performance: September 30,
2021 through September 29, 2026.
Authority: Section 307 of the Public
Health Service Act, as amended (42
U.S.C. 242l).
Dated: August 12, 2021.
Joseph I. Hungate III,
Deputy Director, Office of Financial
Resources, Office of the Chief Operating
Officer, Centers for Disease Control and
Prevention.
[FR Doc. 2021–17678 Filed 8–17–21; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Administration for Children and
Families
Notice of Meeting
Office on Trafficking in
Persons, Administration for Children
and Families, Department of Health and
Human Services.
ACTION: Announcement of meeting and
call for public comments on states’
efforts to improve the nation’s response
to the sex trafficking of children and
youth.
AGENCY:
Notice is hereby given,
pursuant to the provisions of the
Federal Advisory Committee Act
(FACA) and the Preventing Sex
Trafficking and Strengthening Families
Act, that a meeting of the National
Advisory Committee on the Sex
Trafficking of Children and Youth in the
United States (the Committee) will be
held on September 8 and 9, 2021. The
purpose of the meeting is for the
Committee to begin reviewing responses
to the Committee’s State SelfAssessment Survey and develop a
framework for the Committee’s final
report. The members of the Committee
request comments from the public to
inform their ongoing work and final
report. Please submit your comments to
NAC@nhttac.org with the subject ‘‘NAC
Comments’’ as soon as possible and
before September 6, 2021.
DATES: The meeting will be held on
September 8 and 9, 2021.
ADDRESSES: The meeting will be held
virtually. Please register for this event
online: https://www.acf.hhs.gov/otip/
jbell on DSKJLSW7X2PROD with NOTICES
SUMMARY:
VerDate Sep<11>2014
17:34 Aug 17, 2021
Jkt 253001
partnerships/national-advisorycommittee.
FOR FURTHER INFORMATION, CONTACT:
Katherine Chon (Designated Federal
Officer) at EndTrafficking@acf.hhs.gov
or (202) 205–5778, or 330 C Street SW,
Washington, DC 20201. Additional
information is available at https://
www.acf.hhs.gov/otip/partnerships/thenational-advisory-committee.
SUPPLEMENTARY INFORMATION: The
formation and operation on behalf of the
Committee are governed by the
provisions of Public Law 92–463, as
amended (5 U.S.C. App. 2), which sets
forth standards for the formation and
use of federal advisory committees.
Purpose of the Committee: The
purpose of the Committee is to advise
the Secretary and the Attorney General
on practical and general policies
concerning improvements to the
nation’s response to the sex trafficking
of children and youth in the United
States. HHS established the Committee
pursuant to Section 121 of the
Preventing Sex Trafficking and
Strengthening Families Act of 2014
(Pub. L. 113–183).
Tentative Agenda: The agenda can be
found at https://www.acf.hhs.gov/otip/
partnerships/the-national-advisorycommittee. To submit written
statements, email NAC@nhttac.org, by
September 6, 2021. Please include your
name, organization, and phone number.
More details on these options are below.
Public Accessibility to the Meeting:
Pursuant to 5 U.S.C. 552b and 41 CFR
102–3.140 through 102–3.165, and
subject to the availability of space, this
meeting is open to the public virtually.
Written Statements: Pursuant to 41
CFR 102–3.105(j) and 102–3.140 and
section 10(a)(3) of the Federal Advisory
Committee Act, the public may submit
written statements in response to the
stated agenda of the meeting, or to the
Committee’s mission, in general.
Organizations with recommendations
on strategies to engage states and
stakeholders are encouraged to submit
their comments or resources (hyperlinks
preferred). Written comments or
statements received after September 6,
2021, may not be provided to the
Committee until its next meeting.
Verbal Statements: Pursuant to 41
CFR 102–3.140d, the Committee is not
obligated to allow a member of the
public to speak or otherwise address the
Committee during the meeting.
Members of the public are invited to
provide verbal statements during the
Committee meeting only at the time and
manner described in the agenda. The
request to speak should include a brief
statement of the subject matter to be
PO 00000
Frm 00085
Fmt 4703
Sfmt 4703
addressed and should be relevant to the
stated agenda of the meeting or the
Committee’s mission in general.
Minutes: The minutes of this meeting
will be available for public review and
copying within 90 days at: https://
www.acf.hhs.gov/otip/partnerships/thenational-advisory-committee.
Linda Hitt,
Director, Executive Secretariat.
[FR Doc. 2021–17714 Filed 8–17–21; 8:45 am]
BILLING CODE 4184–40–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Government-Owned Inventions;
Availability for Licensing
AGENCY:
National Institutes of Health,
HHS.
ACTION:
Notice.
The invention listed below is
owned by an agency of the U.S.
Government and is available for
licensing to achieve expeditious
commercialization of results of
federally-funded research and
development. Foreign patent
applications are filed on selected
inventions to extend market coverage
for companies and may also be available
for licensing.
FOR FURTHER INFORMATION CONTACT:
Elizabeth Pitts, Ph.D., 240–669–5299;
elizabeth.pitts@nih.gov. Licensing
information may be obtained by
communicating with the indicated
licensing contact at the Technology
Transfer and Intellectual Property
Office, National Institute of Allergy and
Infectious Diseases, 5601 Fishers Lane,
Rockville, MD 20852; tel. 301–496–
2644. A signed Confidential Disclosure
Agreement will be required to receive
copies of unpublished information
related to the invention.
SUPPLEMENTARY INFORMATION:
Technology description follows.
SUMMARY:
Tumor Associated Calcium Signal
Transducer 2 (TACSTD2)Overexpressing Huh7.5 Cells That Are
More Permissive to HCV Cell Entry and
Replication Compared to the Model
Huh7.5 Cell Line
Description of Technology
Worldwide, 130–150 million
individuals are chronically infected
with hepatitis C virus (HCV), a major
cause of liver-associated morbidity and
mortality worldwide. Despite recent
advances in antiviral drugs that can cure
some individuals, a rapid decline of the
E:\FR\FM\18AUN1.SGM
18AUN1
]]>Agencies
[Federal Register Volume 86, Number 157 (Wednesday, August 18, 2021)]
[Notices]
[Page 46258]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-17714]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Administration for Children and Families
Notice of Meeting
AGENCY: Office on Trafficking in Persons, Administration for Children
and Families, Department of Health and Human Services.
ACTION: Announcement of meeting and call for public comments on states'
efforts to improve the nation's response to the sex trafficking of
children and youth.
-----------------------------------------------------------------------
SUMMARY: Notice is hereby given, pursuant to the provisions of the
Federal Advisory Committee Act (FACA) and the Preventing Sex
Trafficking and Strengthening Families Act, that a meeting of the
National Advisory Committee on the Sex Trafficking of Children and
Youth in the United States (the Committee) will be held on September 8
and 9, 2021. The purpose of the meeting is for the Committee to begin
reviewing responses to the Committee's State Self-Assessment Survey and
develop a framework for the Committee's final report. The members of
the Committee request comments from the public to inform their ongoing
work and final report. Please submit your comments to [email protected]
with the subject ``NAC Comments'' as soon as possible and before
September 6, 2021.
DATES: The meeting will be held on September 8 and 9, 2021.
ADDRESSES: The meeting will be held virtually. Please register for this
event online: https://www.acf.hhs.gov/otip/partnerships/national-advisory-committee.
FOR FURTHER INFORMATION, CONTACT: Katherine Chon (Designated Federal
Officer) at [email protected] or (202) 205-5778, or 330 C
Street SW, Washington, DC 20201. Additional information is available at
https://www.acf.hhs.gov/otip/partnerships/the-national-advisory-committee.
SUPPLEMENTARY INFORMATION: The formation and operation on behalf of the
Committee are governed by the provisions of Public Law 92-463, as
amended (5 U.S.C. App. 2), which sets forth standards for the formation
and use of federal advisory committees.
Purpose of the Committee: The purpose of the Committee is to advise
the Secretary and the Attorney General on practical and general
policies concerning improvements to the nation's response to the sex
trafficking of children and youth in the United States. HHS established
the Committee pursuant to Section 121 of the Preventing Sex Trafficking
and Strengthening Families Act of 2014 (Pub. L. 113-183).
Tentative Agenda: The agenda can be found at https://www.acf.hhs.gov/otip/partnerships/the-national-advisory-committee. To
submit written statements, email [email protected], by September 6, 2021.
Please include your name, organization, and phone number. More details
on these options are below.
Public Accessibility to the Meeting: Pursuant to 5 U.S.C. 552b and
41 CFR 102-3.140 through 102-3.165, and subject to the availability of
space, this meeting is open to the public virtually.
Written Statements: Pursuant to 41 CFR 102-3.105(j) and 102-3.140
and section 10(a)(3) of the Federal Advisory Committee Act, the public
may submit written statements in response to the stated agenda of the
meeting, or to the Committee's mission, in general. Organizations with
recommendations on strategies to engage states and stakeholders are
encouraged to submit their comments or resources (hyperlinks
preferred). Written comments or statements received after September 6,
2021, may not be provided to the Committee until its next meeting.
Verbal Statements: Pursuant to 41 CFR 102-3.140d, the Committee is
not obligated to allow a member of the public to speak or otherwise
address the Committee during the meeting. Members of the public are
invited to provide verbal statements during the Committee meeting only
at the time and manner described in the agenda. The request to speak
should include a brief statement of the subject matter to be addressed
and should be relevant to the stated agenda of the meeting or the
Committee's mission in general.
Minutes: The minutes of this meeting will be available for public
review and copying within 90 days at: https://www.acf.hhs.gov/otip/partnerships/the-national-advisory-committee.
Linda Hitt,
Director, Executive Secretariat.
[FR Doc. 2021-17714 Filed 8-17-21; 8:45 am]
BILLING CODE 4184-40-P
